Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
In an exclusive ChinaBio® Today interview, Dr. Jun...
Mindray Medical will pay $105 million to acquire Zonare...
Apexigen, a California antibody company with strong...
Kanghong Pharma Group was granted CFDA approval for a...
WuXi PharmaTech, through its WuXi NextCODE Genomics...
CBT 200 Off By 2 Points. More details...
CBT 200 Climbs 3%. More details...
Acquisitions in the Future -- As expected, a group...
For a change, a China-based biopharma released a Q3...
The dollar value of China’s pharmaceutical market...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
